Senior Research Associate, Protein Analytical Chemistry

Redwood City, CA
Apr 29, 2021
Biotech Bay
Required Education
Bachelors Degree
Position Type
Full time

Senior Associate, Protein Analytical Chemistry

The Position:

The successful candidate will be a key contributor as a large molecule analytical development professional at Bolt. The position will be responsible for development, optimization, and troubleshooting of common monoclonal antibody and antibody drug conjugate analytical methods. The methods will support product release, stability and characterization of Bolt’s Boltbody™ Immune-stimulating Antibody Conjugates (ISACs) in a regulated work environment. This position reports to the Analytical Development Lead.

About You:

You have a BA, BS, and/or MA/MS in biochemistry, analytical chemistry, chemistry or biotechnology or related discipline with at least 8 years BS/BA (5 years MA/MS) of hands-on protein analytical developmental experience at a life-science company. You are proficient with large molecule HPLC, electrophoretic and spectroscopic analytical technologies and understand the operation of the analysis instrumentation tools. You understand the compliance landscape of a GMP environment and demonstrate a working familiarity with GXP regulations, industry guidance and pharmacopeia. You are known for operating in a fast-paced dynamic environment with minimal supervision and managing tight timelines, along with the ability to work in a team environment to suggest solutions to complex problems. You possess good communication skills and aptitude with written documentation, such as technical reports, protocols and standard operating procedures. You are known for creating positive relationships with CMOs, CROs, and employees at all levels and balancing business and stakeholder needs. You have an interest in growing with the company and a commitment to continuous learning.

Who We Are:

Bolt Biotherapeutics, based in the San Francisco Bay Area, is a clinical-stage biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISACs), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies while also developing immunological memory, which may lead to more durable clinical responses for patients. This is a unique opportunity to join and build, with like-minded colleagues, a company that will transform the lives of individuals with cancers.

We are an Equal Opportunity Employer offering a competitive salary and benefits package.